Novel Treatment Advances and Approaches in the Management of Type 2 Diabetes: A Closer Look at the Evolving Role of SGLT2 Inhibitors
Publication
, Journal Article
Green, JB
Published in: Journal of Managed Care Medicine
January 1, 2021
Although cardiovascular and kidney disease are well known complications of diabetes, the use of guideline-directed therapies which reduce these risks are seriously suboptimal. Increasing use of the diabetes medications, along with antihypertensives and lipid-lowering therapies, will reduce risk and should be a goal for providers and managed care.
Duke Scholars
Published In
Journal of Managed Care Medicine
ISSN
1094-1525
Publication Date
January 1, 2021
Volume
24
Issue
2
Start / End Page
67 / 72
Citation
APA
Chicago
ICMJE
MLA
NLM
Green, J. B. (2021). Novel Treatment Advances and Approaches in the Management of Type 2 Diabetes: A Closer Look at the Evolving Role of SGLT2 Inhibitors. Journal of Managed Care Medicine, 24(2), 67–72.
Green, J. B. “Novel Treatment Advances and Approaches in the Management of Type 2 Diabetes: A Closer Look at the Evolving Role of SGLT2 Inhibitors.” Journal of Managed Care Medicine 24, no. 2 (January 1, 2021): 67–72.
Green JB. Novel Treatment Advances and Approaches in the Management of Type 2 Diabetes: A Closer Look at the Evolving Role of SGLT2 Inhibitors. Journal of Managed Care Medicine. 2021 Jan 1;24(2):67–72.
Green, J. B. “Novel Treatment Advances and Approaches in the Management of Type 2 Diabetes: A Closer Look at the Evolving Role of SGLT2 Inhibitors.” Journal of Managed Care Medicine, vol. 24, no. 2, Jan. 2021, pp. 67–72.
Green JB. Novel Treatment Advances and Approaches in the Management of Type 2 Diabetes: A Closer Look at the Evolving Role of SGLT2 Inhibitors. Journal of Managed Care Medicine. 2021 Jan 1;24(2):67–72.
Published In
Journal of Managed Care Medicine
ISSN
1094-1525
Publication Date
January 1, 2021
Volume
24
Issue
2
Start / End Page
67 / 72